Ipca Strikes Biosimilar Technology Transfer Amid Rising Ambitions In The Space
Indian Firm Counts Six MAbs In Its Pipeline, With Two Leading The Pack
Ipca Laboratories underlined its commitment to successfully developing quality and affordable biosimilars meeting global standards as it penned a technology transfer agreement with a fellow Indian firm.
